A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin
Clicks: 359
ID: 274611
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
359 views
62 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #4 of 5 articles by views in journal of gastroenterology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
We report a reactivation of hepatitis B virus infection and a severe hepatitis flare in a patient with chronic hepatitis due to dual infection with hepatitis B and C viruses during combination therapy with alpha-interferon and ribavirin. Pretreatment, HCV was the dominant virus, with detectable seru …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (46 words).
Try re-searching for a better abstract.
| Reference Key |
k2003journala
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yalcin K;Degertekin H;Yildiz F;Kilinc N;; |
| Journal | journal of gastroenterology |
| Year | 2003 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
hepatitis c
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
male
case reports
middle aged
Recurrence
drug therapy
combination
antiviral agents / therapeutic use*
ribavirin / therapeutic use*
hepatitis b
chronic / complications
chronic / virology
chronic / drug therapy*
interferon-alpha / therapeutic use*
virus activation / drug effects
pmid:14505137
doi:10.1007/s00535-002-1149-5
kendal yalcin
halil degertekin
nihal kilinc
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.